Mark Sternlicht

Title: Mark Sternlicht: Innovator in Cancer Research

Introduction

Mark Sternlicht is a prominent inventor based in Los Angeles, CA. He has made significant contributions to the field of cancer research, particularly in the development of methods and compositions for the culture of human primary carcinomas. With a total of 2 patents, his work is paving the way for advancements in cancer treatment and research.

Latest Patents

Mark Sternlicht's latest patents include innovative methods for culturing adenocarcinoma cells. One patent focuses on a basement membrane composition that supports the growth of primary carcinomas and allows for spheroid formation. This invention utilizes feeder layers derived from a human parotid basal cell carcinoma, which can inhibit tumor invasion. Another patent details a method of growing cells in a mammal using a human basement membrane matrix produced by a novel tumorigenic cell line. This matrix is crucial for the growth of various cells in culture and in vivo, especially those resistant to xenografting.

Career Highlights

Mark Sternlicht is affiliated with the University of California, where he continues to advance his research in cancer biology. His work has garnered attention for its potential applications in understanding tumor behavior and developing new therapeutic strategies.

Collaborations

Mark collaborates with Sanford H Barsky, a fellow researcher in the field. Their combined expertise enhances the impact of their research and contributes to the scientific community's understanding of cancer.

Conclusion

Mark Sternlicht's innovative work in cancer research exemplifies the importance of scientific inquiry in developing new treatment methods. His patents reflect a commitment to improving patient outcomes and advancing the field of oncology.